Patent ID: 8017120

Claim:
A method for administering an anti-sclerostin antibody to a human in need thereof, the method comprising administering to said human from about 1 mg/kg to about 3 mg/kg of an anti-sclerostin antibody that (a) demonstrates a binding affinity for sclerostin of SEQ ID NO: 1 of less than or equal to 1×10 −7 M and (b) comprises a CDR-H1 of SEQ ID NO:245, a CDR-H2 of SEQ ID NO:246, a CDR-H3 of SEQ ID NO:247, a CDR-L1 of SEQ NO:78, a CDR-L2 of SEQ ID NO:79 and a CDR-L3 of SEQ ID NO:80.